Form 4: DENTSPLY SIRONA Director Leslie Varon Increases Stake Through RSU Dividends

Sentiment:

Insider Transaction Report


DENTSPLY SIRONA Inc. Director Leslie F. Varon acquired an additional 139.41 shares of common stock through RSU dividends, increasing her total beneficial ownership to 47,826.476 shares.

Summary

  • Leslie F. Varon, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 139.41 shares of common stock.
  • The acquisition occurred on July 11, 2025.
  • These shares were acquired at a price of $0, representing dividends on previously awarded restricted stock units (RSUs).
  • The newly acquired shares are in the form of additional RSUs and are subject to the same vesting terms as the underlying awards.
  • Each RSU converts to common stock on a 1:1 basis.
  • Following this transaction, Leslie F. Varon beneficially owns a total of 47,826.476 shares of DENTSPLY SIRONA Inc. common stock.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even through RSU dividends, generally indicates alignment of interests and confidence in the company's long-term performance. It's a positive signal, though not a direct 'buy' transaction.

Positives

  • Director Leslie F. Varon increased her beneficial ownership in DENTSPLY SIRONA Inc. by 139.41 shares.
  • The acquisition of shares through RSU dividends indicates a mechanism for long-term incentive alignment between the director and shareholders.
  • The shares are subject to vesting, aligning the director's interests with the company's long-term performance.

Future Outlook

This document does not provide a future outlook or guidance. It is a transactional report of insider ownership changes.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. It reflects a standard equity compensation mechanism within the dental products and technologies industry.

Comparison to Industry Standards

  • This document reports a routine insider transaction (acquisition of RSU dividends) and does not contain information for comparison to specific industry benchmarks, comparable companies, projects, or results. Such transactions are common across industries for executive and director compensation.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantLeslie F. Varon granted a Limited Power of Attorney to Richard Rosenzweig, Jessica Causey, and Lindi Barton-Brobst to execute and file Section 16 reports (Forms 3, 4, and 5) on her behalf.2025-05-22Streamlines the process for timely and compliant insider trading disclosures for the director.

Related Party Transactions

  • The transaction involves the acquisition of shares by a director from the company as part of an equity compensation plan, which is a common related-party transaction in the context of executive compensation.

Stakeholder Impact

  • Shareholders: The increase in director ownership, even through RSU dividends, can be viewed positively as it aligns the director's interests with shareholder value.

Next Steps

  • The acquired RSUs are subject to vesting terms, implying future conversion to common stock upon meeting those terms.

Key Dates

DateDescription
2025-05-22Date of execution of the Limited Power of Attorney by Leslie F. Varon.
2025-07-11Date of the reported transaction where Leslie F. Varon acquired common stock.
2025-07-15Date the Form 4 was signed by the attorney-in-fact.

Recommendation

hold

Keywords

DENTSPLY SIRONA, XRAY, Leslie F. Varon, Form 4, Insider Transaction, Restricted Stock Units, RSU Dividends, Director Stock Ownership, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.